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Summary  This  study  aimed  to  investigate  the  prevalence  of  human  brucellosis  in
Najran,  southwestern  Saudi  Arabia,  and  to  assess  the  performances  of  ELISA  and  PCR
as  diagnostic  tools  for  brucellosis  with  respect  to  conventional  methods.  The  study
included  340  patients  with  clinical  characteristics  of  brucellosis.  Blood  samples  from
cases  and  controls  were  subjected  to  culture,  standard  tube  agglutination  test  (SAT),
ELISA  for  IgM  and  IgG,  and  brucella  PCR.  The  diagnosis  of  brucellosis  was  conﬁrmed
in  54  (15.9%)  of  the  340  provisionally  diagnosed  brucellosis  patients.  Blood  culture
identiﬁed  only  14  (25.9%)  cases.  The  SAT  was  positive  for  50  (92.6%)  cases,  whereas
ELISA  IgM,  IgG  and  PCR  were  found  positive  in  46,  52  and  38  cases  respectively.  The
sensitivities  of  ELISA  IgM  and  IgG  were  85.2%  and  96.3%  respectively  and  the  speci-
ﬁcity  was  100%  for  each.  For  PCR,  the  sensitivity  and  speciﬁcity  were  70.4%  and  100%
respectively.  In  conclusion,  ELISA  offers  a  signiﬁcant  advantage  over  conventional
serological  methods  in  the  diagnosis  of  brucellosis  in  endemic  areas.  The  PCR  test
results  can  be  particularly  important  in  patients  with  clinical  signs  and  symptoms,
and  negative  serological  results,  allowing  the  early  and  rapid  conﬁrmation  of  the
brucellosis.
©  2012  King  Saud  Bin  Abdulaziz  University  for  Health  Sciences.  Published  by  Elsevier
Ltd.  All  rights  reserved.
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hntroductionrucellosis  is  a  systemic  disease  caused  by  bac-
eria of  the  genus  Brucella  that  affects  humans
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oi:10.1016/j.jiph.2012.02.001nd  numerous  animal  species.  The  transmission  to
umans occurs  by  the  ingestion  of  raw  or  unpas-
eurized milk  and  other  dairy  products,  by  direct
ontact  with  infected  animal  tissues,  or  by  the
ccidental  ingestion,  inhalation,  or  injection  of
rucella [1].
According  to  the  World  Health  Organization,alf a million  of  new  human  cases  are  reported
ach year,  but  these  numbers  greatly  underesti-
ate the  true  incidence  of  the  disease  in  humans
2]. Although  the  disease  incidence  has  decreased
 Sciences. Published by Elsevier Ltd. All rights reserved.
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markedly  in  industrialized  countries,  brucellosis
remains a  major  public  health  problem  in  many
developing  countries.  In  Saudi  Arabia,  brucellosis  is
hyper-endemic,  with  an  incidence  of  5.4  per  1000
per year.  Its  prevalence  varies  in  different  regions
of the  country,  with  values  of  8.8—8%  having  been
reported  [3].  According  to  Memish  and  Mah  [4],
more than  8000  cases  are  reported  per  year  to  pub-
lic health  authorities.
In humans,  brucellosis  behaves  as  a  systemic
infection with  a  very  heterogeneous  clinical  spec-
trum [5].  The  infection  is  characterized  by  protean
manifestations  and  prolonged  recurrent  febrile
episodes. The  features  of  acute  disease  are  var-
ied and  may  be  insidious,  whereas  the  features
of chronic  disease,  which  may  persist  or  recur  for
years, are  often  vague  [6].  The  disease,  therefore,
cannot be  diagnosed  on  a  clinical  basis  alone,  and
microbiological  conﬁrmation  is  required  through
the isolation  of  Brucella  spp.  from  blood  cultures  or
the detection  of  speciﬁc  antibodies  through  the  use
of serological  tests.  However,  the  established  meth-
ods for  laboratory  diagnosis  are  often  unreliable  in
several respects.
Culturing  is  a  time-consuming  procedure.  Fur-
thermore,  failure  to  detect  the  pathogen  is  a
frequent  occurrence,  and  Brucella  spp.  are  class
III pathogens,  posing  considerable  risk  to  labora-
tory personnel  [7].  The  common  serological  tests
include the  Rose  Bengal  plate  agglutination  test
(RBPT),  the  standard  tube  agglutination  test  (SAT),
the Coombs  test  and  ELISA.  Conventional  serologi-
cal methods  also  have  important  limitations:  their
sensitivity  is  poor  during  the  early  stage  of  the  dis-
ease, and  their  speciﬁcity  is  reduced  in  areas  where
the disease  is  highly  endemic  and  frequent  relapses
of the  disease  occur  [8].  The  development  of  spe-
ciﬁc PCR  assays  is  a  recent  advance  in  the  diagnosis
of human  brucellosis,  but  information  concerning
the use  of  this  diagnostic  tool  is  scarce.
This  study  aimed  to  investigate  the  prevalence
of human  brucellosis  in  Najran,  southwestern  Saudi
Arabia, and  to  assess  the  performances  of  ELISA  and
PCR as  diagnostic  tools  for  brucellosis  with  respect
to conventional  methods.
Materials and methods
From  April  2010  to  September  2011,  a  total  of  340
patients  seen  at  the  Infectious  Diseases  Clinic  of
King Khalid  Hospital  in  Najran  and  presenting  with
clinical characteristics  of  brucellosis  were  included
in this  study.  Based  on  the  duration  of  their  symp-
toms,  the  patients  were  classiﬁed  into  3  groups:
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he acute  group,  with  symptoms  for  <2  months
N =  180);  the  sub-acute  group,  with  symptoms  for
—12 months  (N  =  110);  and  the  chronic  group,  with
ymptoms  for  >1  year  (N  =  50).  One  hundred  healthy
ersonnel  who  were  blood  donors  at  the  hospi-
al’s blood  bank  were  enrolled  as  the  controls;
he median  age  of  controls  was  34.6  years  (range,
8—57);  and  74  were  male,  and  36  were  female.
ight milliliters  of  blood  (5  ml  for  culture  and  serol-
gy and  3  ml  mixed  with  EDTA  for  PCR)  was  obtained
rom  each  patient  and  control.  A  diagnosis  of  bru-
ellosis  was  made  according  to  one  of  the  following
riteria: (i)  the  isolation  of  Brucella  spp.  in  blood
ulture  or  (ii)  the  presence  of  a  compatible  clinical
ssessment  together  with  a positive  result  by  either
AT (at  ≥1/160)  or  ELISA  [8]  or  both.
acteriological and serological techniques
he  blood  cultures  were  processed  inside  a class  III
iological safety  cabinet  [7]  using  biphasic  blood
ulture  medium  (BioMerieux,  France)  and  were
ncubated  at  37 ◦C  in  an  atmosphere  of  5—10%
arbon dioxide  for  30  days;  sub-culturing  was  per-
ormed weekly.  Suspected  colonies  were  identiﬁed
ccording to  standard  techniques  [9].
For serology,  all  of  the  sera  from  the  patients
nd controls  were  tested  using  SAT  and  ELISA  for
gM and  IgG  antibodies  against  Brucella  species.  In
he SAT,  the  serum  samples  were  serially  diluted
n 0.5%  saline,  and  equal  volumes  of  the  dilu-
ions (from  1:10  to  1:1280)  and  of  B.  abortus
nd B.  melitensis  antigens  (Omega  Diagnostic  Ltd,
K) were  mixed  in  test  tubes  and  incubated  in
n incubator  at  37 ◦C  for  24  h.  Known  negative
nd positive  control  sera  were  included.  A titer
f 1/160  was  considered  positive  [8].  The  ELISA
esting  for  IgM  and  IgG  against  Brucella  spp.
as performed  using  commercial  reagents  (Gen-
yme Virotech,  Germany).  The  absorbance  values
btained  were  converted  into  Virotech  units  (VE)
sing the  following  formula,  according  to  the  man-
facturer’s  instructions:  patient  sample  (mean)
bsorbance  ×  10/mean  absorbance  value  of  cut-off
ontrols  (>11  VE  was  considered  positive).  Border-
ine results  were  re-tested  and  conﬁrmed  as  either
ositive  or  negative.
rucella PCR
he  detection  of  a  223-bp  target  sequence  within
he gene  coding  for  the  production  of  a  31-
Da membrane  protein  speciﬁc  to  the  genus
rucella was  performed  by  PCR  using  speciﬁc
rimers (Qiagen,  USA),  as  previously  reported  [10].
he sequences  of  these  primers  were  forward
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Table  1  Distribution  of  laboratory  tests  results  according  to  the  type  of  brucellosis.
Laboratory  test  Brucellosis  groups
Acute,  N  =  180  (%)  Subacute,  N  =  110  (%)  Chronic,  N  =  50  (%)  Total,  N  =  340  (%)
Culture 13  (7.2)  1  (0.9)  0  (0)  14  (4.1)
SAT 28 (15.6)  6 (5.5)  16  (32) 50 (14.7)
ELISA  IgM 32 (17.8)  4 (3.6)  10  (20) 46 (13.1)
ELISA  IgG  28  (15.6)  6  (5.5)  18  (36)  52  (15.3)
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wPCR  32  (17.8)  4  (3.6)  
′-TGGCTCGGTTGCCAATATCAA-3′ and  reverse  5′-
GCGCTTGCCTTTCAGGTCTG-3′ [11].
Serum  samples  from  the  patients  and  controls
ere extracted  for  the  isolation  of  Brucella  DNA
sing the  E.Z.N.A.  commercial  kit  (Omega  Biotech,
SA),  according  to  the  manufacturer’s  instructions.
The PCR  ampliﬁcation  mixture  consisted  of  pure
aq ready-to-go  PCR  beads  (Amersham  Bioscience,
K), 10  pmol/l  of  each  primer  and  50  pg  of  Bru-
ella DNA  extract  in  a  total  volume  of  50  l.  The
mpliﬁcation was  performed  using  a  thermal  cycler
Cyclogene,  Techne,  UK).  The  reaction  mixtures
ere heated  to  90 ◦C  for  5  min,  followed  by  40
mpliﬁcation cycles,  each  consisting  of  60  s  at
0 ◦C,  30  s  at  60 ◦C  and  60  s  at  72 ◦C.  A  ﬁnal  exten-
ion cycle  of  72 ◦C  for  7  min  was  included.  The
mpliﬁed products  were  electrophoresed  through
.5% agarose  gels,  which  were  stained  with  ethid-
um bromide  and  visualized  under  an  ultraviolet
rans-illuminator  (Cole-Parmer,  USA).  The  presence
f an  obvious  band  of  223  bp  was  considered  a pos-
tive result.
tatistical methods
he  data  were  analyzed  using  SPSS  10  for  Win-
ows (SPSS  Inc,  USA).  The  sensitivity,  speciﬁcity,
nd positive  and  negative  predictive  values  were
alculated.
esults
e  studied  a  total  of  340  patients  having  presump-
ive  diagnoses  of  brucellosis.  The  patients  were
etween  19  and  82  years  of  age,  with  a mean
ge of  32.18  years  and  a  standard  deviation  of
11.73  years.  Of  these  patients,  260  (76.5%)  were
ale and  80  (23.5%)  were  female,  for  a  male  to
emale ratio  of  3.3:1.  There  was  no  seasonal  vari-
tion in  the  cases  studied.  The  notable  symptoms
ere fever,  joint  pain,  lower  backache,  headache,
nd vomiting.  The  consumption  of raw  milk  (205
atients)  and  direct  contact  with  domestic  animals
w
w
1
r2  (4)  38  (11.2)
138  patients)  were  recognized  as  the  major  risk
actors for  the  transmission  of  brucellosis  in  our
tudy.
In this  work,  the  diagnosis  of  brucellosis  was
onﬁrmed in  54  (15.9%)  of  the  340  provisionally
iagnosed brucellosis  patients.  Blood  culture  iden-
iﬁed 14  (25.9%)  cases.  The  SAT  was  positive  for
0 (92.6%)  cases,  and  ELISAs  detecting  IgM  and  IgG
ere positive  in  46  (85.2%)  and  52  (96.3%)  cases,
espectively,  whereas  PCR  produced  positive  results
n 38  (70.4%)  cases.  The  distribution  of  the  labora-
ory test  results  among  the  3  brucellosis  groups  is
isted in  Table  1.  The  control  blood  samples  were
ll negative  by  culture,  SAT  and  PCR.
Twenty-one  patients  with  SAT  titers  of  1/160  and
8 patients  with  SAT  titers  of  1/320  yielded  posi-
ive results  in  the  IgM  and  IgG  ELISAs.  The  IgM  and
gG ELISAs  were  positive  for  4  patients  for  whom
he SAT  titer  was  1/80.  The  PCR  test  was  positive
n 38  cases  in  which  the  SAT  titers  were  1/160  (11
ases), 1/320  (17  cases),  1/640  (6  cases)  or  1/1280
4 cases),  as  presented  in  Table  2.  The  sensitivity,
peciﬁcity, and  positive  and  negative  predictive  val-
es of  the  ELISA-IgM,  ELISA-IgG  and  PCR  assays  are
resented in  Table  3.
iscussion
rucellosis  is  an  important  public  health  issue
n many  developing  countries,  including  Mediter-
anean  countries  and  countries  on  the  Arabian
eninsula. The  overall  prevalence  of  human  bru-
ellosis  in  the  present  study  was  16%;  in  an  earlier
eport, the  seroprevalence  rate  was  19%  in  the
outhern  region  of  Saudi  Arabia  [12].  In  a  large-
cale study  investigating  the  seroprevalence  of
rucellosis  in  24,000  subjects  in  different  Saudi
egions  [13],  the  highest  prevalence  of  brucellosis
as found  in  the  northern  and  southern  regions,
ith prevalences  of  20%  and  18.3%,  respectively,
hereas the  prevalences  were  14.6%,  14%  and
1.6% in  the  central,  eastern  and  western  regions,
espectively.  Many  previous  Saudi  studies  [14,15]
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Table  2  Distribution  of  ELISA  and  PCR  results  according  to  SAT  titers.
SAT  titer  No  of  cases  ELISA  IgM  ELISA  IgG  PCR
Positive  Negative  Positive  Negative  Positive  Negative
1/40 96  0  96  0  96  0  96
1/80 194 4 190 4 190 0  194
1/160 18 18 0 18 0 11 7
1/320  21  21  0  21  0  17  4
1/640  7  3  4  7  0  6  1
1/1280  4  0  4  2  2  4  0
Table  3  Diagnostic  yield  of  ELISA  IgM,  ELISA  IgG  and  PCR.
Laboratory  test  Sensitivity  Speciﬁcity  Positive  predictive  value  Negative  predictive  value
ELISA  IgM  85.2%  100%  100%  97.3%
ELISA  IgG  96.3%  100%  100%  99.3%
PCR  70.4%  100%  100%  94.7%
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sshowed  that  the  area  of  residence  (northern  or
southern  region)  has  a  signiﬁcant  effect  on  the  sero-
prevalence.  Border  locations  in  which  there  are
uncontrolled  movements  of  animals  may  have  a
high prevalence  rate,  especially  in  villages  where
Bedouins  live  in  close  contact  with  animals.  How-
ever, in  another  recent  study  in  the  Najran  region
[16], the  prevalence  was  7.3%  among  540  healthy
subjects  based  on  the  IgG  ELISA  (the  only  diag-
nostic technique);  thus,  the  authors  might  have
underestimated  the  true  prevalence  of  the  disease.
It has  been  reported  that  none  of  the  serological
techniques used  in  the  diagnosis  of  brucellosis  are
100% sensitive  and  speciﬁc  [17,18].  Data  from  Mid-
dle Eastern  countries  revealed  seroprevalence  rates
ranging from  8%  in  Jordan  [19]  to  12%  in  Kuwait  [20].
Despite the  important  advances  made  in  the
diagnostics of  human  brucellosis  following  the
introduction  of  automated  blood  culture  tech-
niques,  the  diagnosis  of  this  disease  is  still  based
primarily  on  serological  and  molecular  methods.
Among the  newer  serological  tests,  ELISA  appears
to be  the  most  sensitive  [5,6].  In  this  work,  concor-
dant results  between  the  IgM  and  IgG  ELISA  titers
and the  SAT  titers  were  found  for  88.5%  of  the
patients within  the  three  groups.  Discrepant  results
were obtained  for  6  patients:  4  acute  brucellosis
patients with  negative  SAT  titers  were  positive  by
ELISA for  IgM  and  IgG,  and  2  chronic  brucellosis
patients tested  positive  only  for  the  IgG  ELISA.  This
scenario  for  serological  results  is  very  similar  to  that
reported  elsewhere  in  the  world  [17,21,22]. Mantur
et al.  [17]  also  reported  positive  ELISA  results  for  36
brucellosis  patients,  in  addition  to  positive  IgM  and
IgG ELISA  results  for  16  acute  brucellosis  patients
w
E
i
tnd positive  IgG  ELISA  results  for  18  chronic  brucel-
osis patients  with  negative  IgM  ELISA  and  SAT  titers.
rmak et  al.  [21]  found  that  9%  of  26  acute  brucel-
osis patients  tested  positive  by  the  IgM  assay  and
ested negative  by  the  IgG  assay,  56%  tested  positive
y both  tests,  26%  tested  positive  by  only  the  IgG
ssay, and  9%  tested  negative  by  both  of  the  tests.
t is  known  that  the  IgM  antibody  may  be  detected
fter the  ﬁrst  week  following  the  start  of  the  infec-
ion; the  peak  level  is  reached  4  weeks  later  [22].
lthough  the  IgG  antibody  has  a delayed  appear-
nce, it  is  found  mixed  with  IgM  4  weeks  after  the
nitial antigenic  stimulus;  the  IgM  antibody  level
lways exceeds  the  IgG  antibody  level  during  the
cute stage  of  the  disease.  Our  ﬁndings  agree  with
he principle  that  the  IgM  test  is  more  indicative  of
cute infection,  whereas  IgG  is  more  useful  for  the
iagnosis of  sub-acute  and  chronic  infections.
Different  studies  have  obtained  different  results
egarding  the  sensitivity  and  speciﬁcity  of  ELISA,
ut most  of  these  studies  have  identiﬁed  ELISA  as
he best  diagnostic  test  because  of  its  high  sensi-
ivity. The  sensitivity  and  speciﬁcity  of  ELISA  in  the
resent study  are  in  agreement  with  those  reported
n other  studies  [23,24].  Araj  et  al.  [23]  reported
ensitivities  of  100%  and  91%  for  IgM  and  IgG  ELISAs,
espectively,  and  a  speciﬁcity  of  100%  for  both
ssays. Mantur  et  al.  [17]  reported  an  ELISA  sen-
itivity of 71.3%  and  a  speciﬁcity  of  100%.  Memish
t al.  [24]  found  that  the  respective  sensitivity  and
peciﬁcity  of  the  IgM  ELISA  were  79.1%  and  100%,
hereas  they  were  45.6%  and  97.1%  for  the  IgG
LISA; combining  the  IgM  and  IgG  ELISA  positivities
n their  study  increased  the  sensitivity  to  94.1%  and
he speciﬁcity  to  97.1%.
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[erological  and  molecular  diagnosis  of  human  bruce
PCR-based  assays  are  promising  alternatives  for
he diagnosis  of  brucellosis.  In  this  work,  PCR  cor-
ectly diagnosed  the  32  acute  brucellosis  patients.
n accordance,  Mitka  et  al.  [25]  found  that  the  per-
entage of  PCR-positive  results  among  200  acute
rucellosis  patients  was  99%,  whereas  this  percent-
ge was  91.2%  (31  of  36  patients)  in  the  study  of
urucuoglo  et  al.  [26].  In  contrast,  our  PCR  test
esults  were  only  positive  for  11.1%  of  the  patients
ith chronic  disease.  This  lower  rate  might  be  due
o the  low  bacterial  load  in  the  blood  of  patients
ith chronic  brucellosis.  One  of  the  primary  charac-
eristics  of  the  PCR  assay  that  enhances  its  value,  as
he results  of  the  present  study  conﬁrm,  is its  ability
o establish  the  diagnosis  of  acute  brucellosis.
Although  the  PCR  speciﬁcity  in  this  work  was
00%, its  sensitivity  was  70.4%;  in  previous  stud-
es, the  PCR  sensitivities  varied  from  66%  to  94%
25—28].  The  disparate  results  may  be  related  to  a
ack of  uniformity  and  standardization  among  stud-
es with  regard  to  the  PCR  protocols,  such  as  the
ptimal  clinical  specimen,  sample  volume,  extrac-
ion method,  primer  and  target  sequences,  storage
onditions  of  the  samples  or  experimental  design
25,26].
onclusion
he  results  of  this  study  showed  that  ELISA  offers  a
igniﬁcant advantage  over  conventional  serological
ethods  in  the  diagnosis  of  brucellosis  in  endemic
reas: its  ability  to  measure  2  speciﬁc  antibodies
akes ELISA  an  effective  diagnostic  tool  for  bru-
ellosis.  This  speciﬁcity  is especially  important,  as
t may  be  possible  to  use  ELISA  to  conﬁrm  the
linical stage  of  the  disease.  The  PCR  test  results
an be  particularly  important  in  patients  with  clin-
cal signs  and  symptoms  and  negative  serological
esults, allowing  the  early  and  rapid  conﬁrmation
f the  brucellosis.
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